#dgci

[technomoz]

‘Govt must exercise caution on oral anti-virals’

‘Govt must exercise caution on oral anti-virals’

With India nearing potential approval of an oral antiviral drug such as Merck’s mullopiravir to treat Covid-19, health experts want the government to proceed with caution on its supplies and prices. In a sign of concern about drug resistance, if there is unrestricted use, experts suggest government authorities distribute and store these drugs more closely. Two oral antiviral drugs for the…

View On WordPress

[superpruchika99world]

DCGI allows Serum to enrol 7-11 year olds in Covid vaccine trial

Coronavirus News India's drug regulator on Tuesday allowed vaccine maker Serum Institute to enrol kids aged 7-11 years for its COVID-19 vaccine trial as the country prepares to protect children from the coronavirus.

It has already administered more than 870 million doses to adults among its population of nearly 1.4 billion.

ALSO READ: Second wave of Covid-19 spawns black mkt for oxygen, drugs: Survey

"After detailed deliberation, the committee recommended for allowing enrolment of subjects of 7 to 11 years of age group as per the protocol," a subject expert panel of the Central Drugs Standard Control Organization said.

Serum Institute is already conducting a trial of its COVID-19 vaccine, a domestically produced version of AstraZeneca's shot, in the 12-17 age group and has presented safety data for an initial 100 participants...Read more.